Keywords: cortecs, banks, oral, insulin, product, wake, macritonin

Cortecs banks on oral insulin product in wake of Macritonin failure

Article | 01 July 1999

Beleaguered UK biotechnology company Cortecs, which following anexternal review is positioning itself as an early-stage R&D company, last week ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in